These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 20121479
1. Proteomics in prostate cancer biomarker discovery. Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C, Townsend PA. Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479 [Abstract] [Full Text] [Related]
2. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy. Fredolini C, Liotta LA, Petricoin EF. Crit Rev Clin Lab Sci; 2010 Feb; 47(3):125-38. PubMed ID: 20858067 [Abstract] [Full Text] [Related]
5. Biomarkers for prostate cancer detection. Parekh DJ, Ankerst DP, Troyer D, Srivastava S, Thompson IM. J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845 [Abstract] [Full Text] [Related]
6. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Bharti A, Ma PC, Salgia R. Mass Spectrom Rev; 2007 Dec; 26(3):451-66. PubMed ID: 17407130 [Abstract] [Full Text] [Related]
7. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK, Tyson DR. Urol Oncol; 2006 Dec; 24(3):231-6. PubMed ID: 16678055 [Abstract] [Full Text] [Related]
12. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective. Matharoo-Ball B, Ball G, Rees R. Vaccine; 2007 Sep 27; 25 Suppl 2():B110-21. PubMed ID: 17916461 [Abstract] [Full Text] [Related]
13. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z. Biostatistics; 2003 Jul 27; 4(3):449-63. PubMed ID: 12925511 [Abstract] [Full Text] [Related]
14. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. Sardana G, Jung K, Stephan C, Diamandis EP. J Proteome Res; 2008 Aug 27; 7(8):3329-38. PubMed ID: 18578523 [Abstract] [Full Text] [Related]
15. Proteomics: new technologies and clinical applications. Latterich M, Abramovitz M, Leyland-Jones B. Eur J Cancer; 2008 Dec 27; 44(18):2737-41. PubMed ID: 18977654 [Abstract] [Full Text] [Related]
16. Cancer biomarkers: knowing the present and predicting the future. Chatterjee SK, Zetter BR. Future Oncol; 2005 Feb 27; 1(1):37-50. PubMed ID: 16555974 [Abstract] [Full Text] [Related]
17. Proteomic approaches for serum biomarker discovery in cancer. Maurya P, Meleady P, Dowling P, Clynes M. Anticancer Res; 2007 Feb 27; 27(3A):1247-55. PubMed ID: 17593616 [Abstract] [Full Text] [Related]
20. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions. Jurisicova A, Jurisica I, Kislinger T. Expert Rev Proteomics; 2008 Aug 27; 5(4):551-60. PubMed ID: 18761466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]